Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer

NCT01130584 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01130584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01130584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
April 30, 2013
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer